Lyophilized vial
Retatrutide
Triple-agonist peptide studied at the GLP-1, GIP and glucagon receptors.
$105.00
GLP Research · Metabolic
Tirzepatide
Third-party tested · COA with every order
CAS2023788-19-2FormulaC225H348N48O68MW4813.45
Dual GIP / GLP-1 receptor agonist for incretin-signalling research.
- Independently tested
- Lot-matched COA
- Lyophilized for stability
- Ships from the USA
Research use only. Not for human or veterinary use. Sold to qualified researchers aged 21+.
SizePO-TIRZEPATIDE-10
$100.00
1
Lot-matched documentation. Every order ships with the certificate for its lot. If a vial arrives damaged or doesn't match its paperwork, tell us within 72 hours and we'll replace it.
About Tirzepatide
Dual GIP / GLP-1 receptor agonist for incretin-signalling research.
Supplied as
10 mg per unit, as a lyophilized powder in a sealed glass vial with a crimped cap. The lot number on the label matches the certificate of analysis in the COA library.
Storage and handling
Store lyophilized powder frozen (−20 °C) or refrigerated, sealed and away from light. Once reconstituted, keep refrigerated (2–8 °C).
Handle in a laboratory setting using appropriate protective equipment. Consult the certificate of analysis and safety data for lot-specific information.
Important research notice. This product is intended solely for in-vitro and laboratory research. It is not a drug, food, supplement or cosmetic, has not been evaluated by the FDA, and must not be used in humans or animals. Peptides Only does not provide usage or dosing information.
More GLP Research
View all You might also need
Lyophilized vial
Semaglutide
Long-acting GLP-1 receptor agonist analogue for metabolic pathway studies.
$60.00
Lyophilized vial
Retatrutide + Cagrilintide
Pre-combined triple agonist and amylin analogue in a single vial.
$200.00